A GWAS for IgA Nephropathy, the Most Common form of Glomerulonephritis
A GWAS for IgA Nephropathy, the Most Common form of Glomerulonephritis
批准号:
7939672
负责人:
ALI G GHARAVI
金额:
$49.88万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-07-31
关键词:
17q2q344q216q227q31AddressAntigen-Antibody ComplexAsiansAwardBiopsyCandidate Disease GeneCaucasiansCaucasoid RaceCharacteristicsChinaChinese PeopleChromosomesComplexComplex Genetic TraitData AnalysesDepositionDetectionDevelopmentDiagnosisDiagnosticDiseaseEuropeEuropeanGeneral PopulationGenesGeneticGenotypeGlomerulonephritisHandHigh PrevalenceHousingImmuneImmunoglobulin AImmunoglobulinsInjuryInternationalKidneyKidney DiseasesKidney FailureLifeMediatingNorth AmericaOnline Mendelian Inheritance In ManPathogenesisPatientsPhasePhenotypePlayPopulationPopulation StudyPredispositionRecruitment ActivityRoleSampling StudiesSignal TransductionSiteStratificationTechnologyTherapeuticUncertaintyVariantWorkbasecase controlcohortgenetic variantgenome wide association studygenome-wideinsightnovelpublic health relevancetooltrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In this study, we propose to perform the first genome-wide association study (GWAS) for Immunoglobulin A Nephropathy (IgAN, OMIM %161950), an understudied disease that is a major cause of kidney failure in the U.S. and worldwide. It is the most common cause of kidney failure among Asian populations, and the most common form of primary glomerulonephritis among young Caucasians. Similar to many immune mediated disorders, IgAN is a genetically complex trait and genetic basis for disease is not known. To perform a GWAS, we have assembled the largest international case/control cohort of IgAN. This study population consists of a Chinese cohort recruited from Beijing and Shanghai ( >2,000 biopsy-documented cases of IgAN and >2,000 healthy controls) and a Caucasian/European cohort recruited the North America and Europe (>2000 biopsydocumented cases and 2000 controls), with the recruitment ongoing at four study sites. Critically, all the samples for these studies are in hand. Initial genotyping of 551 cases and 441 controls from Beijing, China (Illumina 610quad chip). Analyses of the data demonstrated absence of significant stratification (?=1.005) and revealed genome-wide significant association of IgAN with the HLA-DQA2 locus (p=9x10-8). In addition, In addition, this modest-sized cohort revealed several suggestive associations on chromosomes 7q31 (p=7x10-6), 15q13 (p=8x10-6), 4q21 (p=2x10-5), and 3q26.2 (p=3x10-5), highlighting novel candidate genes for disease. In this project, we propose to complete the genotyping of the Beijing cohort (total of 1200 IgAN cases/1200 controls) to identify common variants with modest to large effects on disease. We will next replicate these findings in independent cohorts from Shanghai (750 cases/750 controls) and Caucasians from North America/Europe (2000 cases/2000 controls). These studies will provide insight into the pathogenesis of IgAN, providing novel opportunities for development of diagnostic and therapeutic tools for this major cause of kidney failure.
PUBLIC HEALTH RELEVANCE: Immunoglobulin A Nephropathy (IgAN, OMIM %161950), an understudied disease that is a major cause of kidney failure in the U.S. and worldwide. These genetic studies will provide insight into the pathogenesis of IgAN, providing novel opportunities for development of diagnostic and therapeutic tools for this major cause of kidney failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO
-
批准号:9525197
-
项目类别:
-
资助金额:$212.9万
-
财政年份:2016
-
负责人:ALI G GHARAVI
-
依托单位:
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO
-
批准号:9228787
-
项目类别:
-
资助金额:$446.13万
-
财政年份:2016
-
负责人:ALI G GHARAVI
-
依托单位:
Columbia GENIE (GENomic Integration with Ehr)
-
批准号:9134799
-
项目类别:
-
资助金额:$85.98万
-
财政年份:2015
-
负责人:ALI G GHARAVI
-
依托单位:
Columbia GENIE (GENomic Integration with Ehr)
-
批准号:9896294
-
项目类别:
-
资助金额:$70.74万
-
财政年份:2015
-
负责人:ALI G GHARAVI
-
依托单位:
Columbia GENIE (GENomic Integration with Ehr)
-
批准号:8968053
-
项目类别:
-
资助金额:$85.95万
-
财政年份:2015
-
负责人:ALI G GHARAVI
-
依托单位:
Human genetic approaches to lower urinary tract phenotypes
-
批准号:10297545
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2014
-
负责人:ALI G GHARAVI
-
依托单位:
The Host Genome and the Urinary Microbiome in UTI and GU Structural Defects
-
批准号:10022308
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2014
-
负责人:ALI G GHARAVI
-
依托单位:
Human genetic approaches to lower urinary tract phenotypes
-
批准号:10700954
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2014
-
负责人:ALI G GHARAVI
-
依托单位:
Human genetic approaches to lower urinary tract phenotypes
-
批准号:10487492
-
项目类别:
-
资助金额:$23.36万
-
财政年份:2014
-
负责人:ALI G GHARAVI
-
依托单位:
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
-
批准号:10212101
-
项目类别:
-
资助金额:$16.2万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
-
批准号:8924174
-
项目类别:
-
资助金额:$6.21万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
-
批准号:8733168
-
项目类别:
-
资助金额:$80.52万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
-
批准号:8914614
-
项目类别:
-
资助金额:$80.52万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
-
批准号:8628397
-
项目类别:
-
资助金额:$53.95万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
-
批准号:10165699
-
项目类别:
-
资助金额:$100.07万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
-
批准号:10414152
-
项目类别:
-
资助金额:$94.38万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
The Columbia PCC for CureGN: the Cure Glomerulonephropathy network
-
批准号:10691635
-
项目类别:
-
资助金额:$59.79万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
-
批准号:9310239
-
项目类别:
-
资助金额:$80.52万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Advancing Clinical Research in Primary Glomerular Diseases (UM1)
-
批准号:9130499
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2013
-
负责人:ALI G GHARAVI
-
依托单位:
Discovery and fine mapping of susceptibility loci for IgA nephropathy
-
批准号:8719093
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2012
-
负责人:ALI G GHARAVI
-
依托单位:
海外基金